Amid the COVID-19 pandemic, interest in probiotics and prebiotics has surged. Probiotics, beneficial bacteria known for supporting gut health, may play a role in immune function. Studies suggest they could potentially modulate the body's immune response, possibly aiding in fighting respiratory infections like COVID-19. Prebiotics, the fuel for probiotics, promote their growth and activity. While they don't directly impact the virus, they foster a healthy gut environment, indirectly supporting immune function. However, caution is warranted; while promising, probiotics aren't a substitute for vaccines or proven treatments. Consultation with healthcare professionals is essential before integrating them into your routine, especially for those with underlying health conditions. As research progresses, understanding the interplay between probiotics, prebiotics, and COVID-19 may offer valuable insights into preventative health measures.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India